| Safety and Efficacy Study of reSept ASD Occluder for Treating Secundum ASD (NCT04591392) | atHeart Medical | 2021-03-12 |
| Safety and Efficacy Study of Absnow Absorbable ASD Closure System For Treating ASD Patients (NCT03601039) | Lifetech Scientific (Shenzhen) Co., Ltd. | 2018-08-25 |
| The Effect on EPCs by Successful Cardiac Occlusion Device Implantation (NCT02957201) | University Hospitals of North Midlands NHS Trust | 2016-07-01 |
| Comparative Effects of Dexmedetomidine and Ketofol for Sedation in Patients Undergoing Trans-esophageal Echocardiography (NCT02867930) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2016-06-01 |
| MitraClip® and Hemodynamic Effects of Relevant Iatrogenic Atrial Septum Defect Closure (NCT03024268) | Heart Center Leipzig - University Hospital | 2016-01-01 |
| Fluid Balance During Closure of Atrial Septal Defect (NCT01757743) | Oslo University Hospital | 2013-02-01 |
| Bosentan for Mild Pulmonary Vascular Disease in Asd Patients. (NCT01218607) | Universitaire Ziekenhuizen KU Leuven | 2010-10-01 |
| Procedural Success and Safety of the Nit-Occlud® Patent Foramen Ovale (PFO) Closure Device and Its Application System (NCT00968032) | pfm medical gmbh | 2009-07-01 |
| ESCAPE Migraine Trial (NCT00267371) | Abbott Medical Devices | 2005-11-01 |
| PC-Trial: Patent Foramen Ovale and Cryptogenic Embolism (NCT00166257) | Foundation for Cardiovascular Research, Zurich | 2000-02-01 |
| Molecular Genetic Epidemiology of Three Cardiac Defects -SCOR in Pediatric Cardiovascular Disease (NCT00005546) | National Heart, Lung, and Blood Institute (NHLBI) | 1999-01-01 |
| Molecular Genetic Epidemiology of Endocardial Cushion Defects - SCOR in Pediatric Cardiovascular Disease (NCT00005322) | National Heart, Lung, and Blood Institute (NHLBI) | 1990-01-01 |